Skip to main content

Acute Urinary Retention

  • Chapter
  • First Online:
Urology at a Glance

Abstract

Acute urinary retention (AUR) is a painful urologic emergency specifically characterized by the sudden inability to urinate. It remains the most common urologic emergency managed by urologists worldwide and is a condition seen by all physicians regardless of their specialty. Population-based cohort studies in the United States and Belgium have put the incidence of AUR at 2.2–6.8 episodes per 1,000 man-years, but older studies have it as high as 130 episodes per 1,000 man-years [1–3, 5, 9, 11]. There is a significantly higher rate in the male population with benign prostatic hypertrophy (BPH). Due to the low occurrence rate in women, data on incidence is not readily available for the female population. Across numerous studies, the major risk factors for development of AUR in men are the following: age (age >70, RR 7.8), symptom severity (AUA symptom score >7, RR 3.2), prostate size (volume >30 mL, RR 3.0), and urinary flow rate (flow rate <12 mL/s, RR 3.9) [9, 13, 16]. Age is the predominant risk factor, with a nearly linear increase in incidence with age – up to 10 % of men over the age of 70 and almost one-third of men over the age of 80. While a variety of pathophysiologic mechanisms may contribute to the development of AUR, the three predominant mechanisms are outflow obstruction, neurologic impairment, and overdistension.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 79.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Ball AJ, Feneley RC, Abrams PH. The natural history of untreated prostatism. Br J Urol. 1981;53:613–6.

    Article  PubMed  CAS  Google Scholar 

  2. Barry MJ, Fowler FJ, Bin L, et al. The natural history of patients with benign prostatic hyperplasia as diagnosed by North American urologists. J Urol. 1997;157:10–5.

    Article  PubMed  CAS  Google Scholar 

  3. Birkhoff JD, Wiederhorn AR, Hamilton ML, Zinsser HH. Natural history of benign prostatic hypertrophy and acute urinary retention. Urology. 1976;7:48–52.

    Article  PubMed  CAS  Google Scholar 

  4. Chan P, Wong W, Chan L, Cheng C. Can terazosin relieve acute urinary retention and obviate the need for an indwelling urethral catheter? Br J Urol. 1996;77:7.

    Article  Google Scholar 

  5. Craigen AA, Hickling JB, Saunders CR, Carpenter RG. Natural history of prostatic obstruction: a prospective survey. J R Coll Gen Pract. 1969;18:226–32.

    PubMed  CAS  PubMed Central  Google Scholar 

  6. Fitzpatrick JM, Kirby RS. Management of acute urinary retention. BJU Int. 2006;97(2):16.

    Article  PubMed  Google Scholar 

  7. Horgan AF, Prasad B, Waldron DJ, O’Sullivan DC. Acute urinary retention. Comparison of suprapubic and urethral catheterization. Br J Urol. 1992;81:712.

    Google Scholar 

  8. Ichsan J, Hunt DR. Suprapubic catheters: a comparison of suprapubic versus urethral catheters in the treatment of acute urinary retention. Aust N Z J Surg. 1987;57:33.

    Article  PubMed  CAS  Google Scholar 

  9. Jacobsen SJ, Jacobsen DJ, Girman CJ, et al. Natural history of prostatism: risk factors for acute urinary retention. J Urol. 1997;158:481–7.

    Article  PubMed  CAS  Google Scholar 

  10. Klarskov P, Andersen JT, Asmussen CF, et al. Symptoms and signs predictive of the voiding pattern after acute urinary retention in men. Scand J Urol Nephrol. 1987;21:23.

    Article  PubMed  CAS  Google Scholar 

  11. McConnell JD, Bruskewitz R, Walsh P, et al. The effect of finasteride on the risk of acute urinary retention and the need for surgical treatment among men with benign prostatic hyperplasia. Finasteride Long-Term Efficacy and Safety Study Group. N Engl J Med. 1998;338:557–63.

    Article  PubMed  CAS  Google Scholar 

  12. McNeill SA, Daruwala PD, Mitchell ID, et al. Sustained-release alfuzosin and trial without catheter after acute urinary retention: a prospective, placebo-controlled. BJU Int. 1999;84:622–7.

    Article  PubMed  CAS  Google Scholar 

  13. Meigs JB, Barry MJ, Giovannucci E, et al. Incidence rates and risk factors for acute urinary retention: the health professionals follow-up study. J Urol. 1999;162:376–82.

    Article  PubMed  CAS  Google Scholar 

  14. Ramsey S, Palmer M. The management of female urinary retention. Int Urol Nephrol. 2006;38:533.

    Article  PubMed  Google Scholar 

  15. Roehrborn CG. Acute urinary retention: risks and management. Rev Urol. 2005;7(4):S31–44.

    PubMed  PubMed Central  Google Scholar 

  16. Roehrborn CG, Bruskewitz R, Nickel GC, et al. Urinary retention in patients with BPH treated with finasteride or placebo over 4 years. Characterization of patients and ultimate outcomes. The PLESS Study Group. Eur Urol. 2000;37:528–36.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Derya Tilki MD .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Chandrasekar, T., Tilki, D. (2014). Acute Urinary Retention. In: Merseburger, A., Kuczyk, M., Moul, J. (eds) Urology at a Glance. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-54859-8_38

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-54859-8_38

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-54858-1

  • Online ISBN: 978-3-642-54859-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics